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Despite advances in antibiotic therapy aimed at preventing
the valvular inflammation and distortion that is character-
istic of rheumatic mitral valve disease, this condition con-
tinues to be a major health problem worldwide. For the past
25 years, echocardiography has played a crucial role in
diagnosing the presence and severity of rheumatic valvular
heart disease. With advances in interventional therapies,
echocardiography has continued to play a pivotal role in
assessing patients before and after interventions. Twenty-
five years ago, Henry et al. (1) reported on the ability of the
then-new field of two-dimensional echocardiography to
planimeter the mitral valve orifice. The following years led
to the development of Doppler echocardiography, which
provided hemodynamic information about rheumatic heart
disease; and in the last decade, transesophageal echocardi-
ography (TEE) has played a key role in both selecting
patients for, and evaluating patients during, percutaneous
valvuloplasty.
Echocardiography is unique in that it allows both ana-
tomic and hemodynamic assessment of the complex mitral
valve apparatus. In addition, it provides anatomic and
hemodynamic information about other associated valvular
abnormalities, as well as direct information about the effects
of the rheumatic process on cardiac chambers. Planimetry of
the mitral orifice has been considered the noninvasive gold
standard when determining the severity of mitral stenosis.
This measurement is independent of hemodynamic vari-
ables, including left ventricular diastolic compliance.
Echocardiography is a technique that relies on accurate
performance and interpretation for its proper utilization.
Awareness of potential technical and interpretive pitfalls is
central to its application in diagnosing known or suspected
cardiovascular conditions. Over 20 years ago, my colleagues
and I (2) highlighted the technical problems that could lead
to errors in accurate planimetry of the mitral valve orifice.
This fact, as well as the fact that transthoracic echocardi-
ography (TTE) provided adequate visualization of the
mitral valve orifice in only three-fourths of the patients with
known rheumatic mitral valve disease, led to the welcoming
of the field of Doppler echocardiography as an additional
noninvasive method for determining the severity of rheu-
matic mitral valve disease. Hatle et al. (3) introduced the
concept of Doppler evaluation of mean mitral gradients and
valve area by spectral Doppler echocardiography. Despite
these advances, it must be remembered that both the
Doppler technique and the catheterization technique pro-
vide only indirect measurements of the mitral valve orifice
area, with the true cross-sectional area of the rheumatic
mitral valve being the gold standard for quantitating the
severity of mitral stenosis.
See page 1355
In this issue of the Journal, Binder et al. (4) introduced
the concept of real-time volumetric echocardiography
(RTVT) to the evaluation and understanding of the rheu-
matic mitral valve. This technique utilizes a matrix-array
echocardiographic probe that provides instantaneous acqui-
sition of a data set within a pyramidal volume. The dramatic
aspect is that this data set is obtained in one cardiac cycle,
which makes possible the reconstruction of any two-
dimensional echocardiographic plane from a single volu-
metric set that is independent of the echocardiographic
“window” from which the data were acquired. Real-time
volumetric echocardiography provides two intersecting or-
thagonal long-axis scans in a B plane, with a perpendicular
short-axis C-scan line that can be angled at 1° and moved up
and down in the pyramidal volume in 1.0-mm slices. The
ability to provide multiple two-dimensional echocardio-
graphic planes in any image orientation is a unique advan-
tage of this technology.
Binder et al. (4) compared this technique with standard
TTE (including Doppler) in 48 patients with known mitral
valve stenosis. The authors found that RTVT was extremely
accurate, especially when taking into account interobserver
variability. Also of note is that this technology allowed for
rapid assessment of the severity of mitral stenosis by
allowing complete acquisition of data and analysis in less
than 5 min per patient. Finally, the authors highlight the
difficulties encountered by standard TTE, whereas minor
alterations in image plane and short-axis views of the mitral
orifice can lead to major overestimations of the mitral valve
orifice size. The authors point out that RTVT improves
both performance time and accuracy in evaluating patients
with mitral stenosis, both of which are important advances
in today’s outcome-oriented health care environment.
Binder et al. (4) obtained good echocardiographic images
in all 48 patients scanned by RTVT, whereas standard TTE
provided adequate images for planimetry in only 89% of
patients. The fact that this technique may provide excellent
images for evaluating the mitral valve orifice in all (or nearly
all) patients would be a major advance in the noninvasive
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assessment of rheumatic mitral valve stenosis. Binder et al.
also point out how minor changes in the depth or angle of
interrogation of the standard transthoracic ultrasound beam
can lead to overestimation of the mitral valve area by
anywhere from 63% to 83%—information that should be
instructive for all those performing routine TTE for patients
with known or suspected mitral valve stenosis.
In the mid 1980s, Inoue et al. (5) introduced the concept
of percutaneous balloon valvuloplasty—a tremendous ad-
vance in the treatment of rheumatic mitral stenosis. Echo-
cardiography has played a crucial role in patient selection
because selection is tied not only to the degree of mitral
orifice stenosis but also to variables such as leaflet mobility,
leaflet thickening, degree of calcification of the leaflets and
the presence or absence of left atrial and left atrial append-
age thrombus. Real-time volumetric three-dimensional
echocardiography appears to provide accurate information,
not only about mitral valve orifice area but also about the
morphology of the mitral valve and its subvalvular appara-
tus. Therefore, this technique should play a central role in
aiding with patient selection for balloon valvuloplasty, as
well as in the evaluation of the outcome of using the
technique, once it has been performed.
What are the limitations of the current study? The
authors did not have an anatomic gold standard (i.e., true
pathologic inspection of the valve, either at operation or
postmortem). Also, the authors offered no correlation with
catheter-based data (Gorland formula), even though the
limitations of the latter are well recognized. Most worri-
some is the fact that the authors did not assess the accuracy
of RTVT in the seven patients who had undergone previous
mitral interventions (three with surgical valvulotomy and
four with percutaneous balloon valvuloplasty). Because it is
likely that these valves had undergone further distortion, it
would be important to know whether RTVT had more
difficulty assessing the mitral valve orifice in these patients
versus the 41 patients who had not undergone previous
interventions.
This is not the first time that three-dimensional evalua-
tion of the mitral orifice has been attempted by echocardio-
graphic techniques. Others have coupled TEE with com-
puter reconstruction to provide three-dimensional images of
the mitral valve orifice (6). The obvious advantage of RTVT
is that it allows for rapid acquisition and analysis of the data
(not relying on time-consuming computer reconstruction),
compared with the transthoracic approach. An obvious
limitation, though, is that unlike TEE, it is unknown how
much data this technique would provide about left atrial and
left atrial appendage anatomy.
What does the future hold? Combining anatomic infor-
mation provided by RTVT with Doppler color flow imag-
ing information should allow for more accurate assessment
of the presence and severity of both stenosis and regurgita-
tion of not only the mitral, but also any other valvular
structure. The ability of this technique to potentially offer
color Doppler variables in a three-dimensional real-time
method should allow important anatomic and functional
information about volumetric flows across stenotic or regur-
gitant valves. Applying this technology to abnormalities of
the aortic valve would be a further advance in the evaluation
of patients with known or suspected significant aortic
stenosis and regurgitation. Finally, coupling RTVT with the
transesophageal approach would lead to advances in the
diagnosis and management of various cardiovascular condi-
tions, including thoracic aortic abnormalities.
What should we take away from this report? First, one
needs to remember the complexity of the mitral apparatus
and how the complete evaluation of its components is
necessary to understand the pathophysiologic impact of a
disease process, such as rheumatic mitral valve disease.
Second, we must remember that rheumatic disease can
involve, directly or indirectly, other valvular structures and
other anatomic entities, such as the left atrial appendage.
Therefore, noninvasive evaluation of rheumatic mitral valve
disease involves much more than simply calculating the
mitral valve orifice area. It is essential to obtain data on
involvement of other valves, such as the tricuspid valve, as
well as right-sided hemodynamic data and anatomic abnor-
malities, such as left atrial appendage thrombi. Any tech-
nology, especially any noninvasive technology, offers the
echocardiographer the ability to fully ascertain the conse-
quences of the disease process, so that appropriate manage-
ment decisions can be made.
Right or wrong, we live in a world where speed counts.
Volumetric three-dimensional echocardiography allows for
the near-instantaneous acquisition of a complete three-
dimensional data set from one acoustic window. Theoreti-
cally and realistically, RTVT should offer dramatic improve-
ments in the speed of TTE. However, this speed should
never come without accuracy. Accuracy, after all, is the gold
standard on which all outcomes data will be based. At the
very least, technological advances, like RTVT, allow for a
better understanding of the limitations of current trans-
thoracic technology. It appears that this technique may
improve the accuracy of standard TTE for quantitating
mitral valve stenosis. If RTVT technology can be applied
both to real-time flow analysis and to TEE, dramatic
improvements in noninvasive diagnosis will be possible.
Our goal in medicine is to always improve the care and
outcome for a single patient. Reports such as Binder et al.
(4) provide us with a glimpse into what advances in
technology offer in our search for better care for the
individual patient. By helping us to understand the limita-
tions of current technology, this study should make all who
incorporate echocardiography into their daily practice of
cardiology better providers of care.
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